The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study-Reference-Cited by-同舟云学术

The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study

Published:2017-11-22 Issue:25 Volume:1 Page:2392-2398
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Jonsdottir Gudbjörg¹²,Lund Sigrún H.¹,Björkholm Magnus³,Turesson Ingemar⁴,Hultcrantz Malin³⁵,Porwit Anna⁶,Jethava Yogesh S.⁷,Landgren Ola⁵,Kristinsson Sigurdur Y.¹³

Affiliation:

1. Faculty of Medicine, University of Iceland, Reykjavik, Iceland;

2. Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA;

3. Division of Hematology, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden;

4. Department of Hematology, Skåne University Hospital, Malmö, Sweden;

5. Myeloma Service, Memorial Sloan Kettering Cancer Center, New York, NY;

6. Division of Oncology and Pathology, Department of Clinical Sciences, Faculty of Medicine, Lund University, Lund, Sweden; and

7. Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA

Abstract

Key Points Prior malignancy negatively impacts survival in patients with MM and >1 prior malignancy reduces survival even further. A prior malignancy diagnosis increases the risk of developing a second malignancy in patients with MM.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/1/25/2392/879173/advances007930.pdf

Reference43 articles.

1. Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years;Engelhardt;Haematologica,2015

2. Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma;Hasskarl;Leuk Lymphoma,2011

3. Secondary primary malignancies in multiple myeloma: an old NEMESIS revisited;Yang,2012

4. Second malignancies after multiple myeloma: from 1960s to 2010s;Thomas;Blood,2012

5. Myeloma and second primary cancers;Landgren;N Engl J Med,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changing trends in the risk factors for second primary malignancies after autologous stem cell transplantation for multiple myeloma before and after the introduction of proteasome inhibitors and immunomodulatory drugs;Haematologica;2023-07-20

2. Increased mortality risk in multiple-myeloma patients with subsequent malignancies: a population-based study in the Netherlands;Blood Cancer Journal;2022-03-15

3. Significant current epidemiological trend: Haematological malignancies as subsequent primary tumours in cancer patients;Cancer Epidemiology;2021-06

4. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma;European Journal of Haematology;2021-05-28

5. Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies;American Journal of Roentgenology;2021-04-28